Asia's largest slum Dharavi in Mumbai (India) is now COVID free
As the vaccine drive is picking up in the United Kingdom amid the scare of new strain of Covid-19, the University of Birmingham has come out with a nasal spray which it says "protects against coronavirus and prevents transmission".
Elsewhere, the University of Louisville in the US received $8.5 million in funding last month from the U.S. Department of Defense (DoD) to develop a nasal spray to prevent COVID-19 using Q-Griffithsin, a drug compound developed and co-owned by UofL but it may take another year. Pending clinical trials, Birmingham researchers say the nasal spray works by catching Covid-19 inside the nose, where it can theoretically leave the body through blowing the nose or swallowing.